Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-25

Clinical Trial Update: Phase III Randomized Trial of Adjuvant Chemotherapy With S-1 vs S-1/Oxaliplatin ± Radiotherapy for Completely Resected Gastric Adenocarcinoma : The ARTIST II Trial [Phase 3]

View source ↗

Summary

Phase III randomized trial evaluating adjuvant chemotherapy with S-1 versus S-1/Oxaliplatin with or without radiotherapy for completely resected gastric adenoca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OXALIPLATIN (Oxaliplatin)
  • S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Samsung Medical Center | Conditions: Gastric Cancer | Phase 3 | Status: UNKNOWN